arrow
Y

Yaling Han

General Hospital of Northern Theater Command
H指数:56
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bivalirudin Versus Heparin in Low and Non-Low Bleeding Risk Patients Undergoing Primary PCI for STEMI

比伐卢定与肝素在低出血风险和非低出血风险患者行ST段抬高型心肌梗死直接经皮冠状动脉介入治疗中的比较

2026-08-280
PRE
Ticagrelor vs. clopidogrel in bivalirudin-treated patients with STEMI undergoing primary PCI: The BRIGHT-4 trial

替格瑞洛与氯吡格雷在比伐卢定治疗的ST段抬高型心肌梗死患者行经皮冠状动脉介入治疗中的比较:BRIGHT-4试验

2026-02-011
PRE
Coronary CT Angiography Quantitative Features and Outcomes After Complete Revascularization in Acute Coronary Syndrome: A Post Hoc Analysis of a Prospective PCI Registry

冠状动脉CT血管造影定量特征及完全血运重建后急性冠状动脉综合征的结局:一项前瞻性PCI注册研究的事后分析

2025-12-260
PRE
Corrigendum to “Comparison of clopidogrel monotherapy versus prolonged DAPT based on the GRACE score in patients with acute coronary syndromes at High Ischemic and Bleeding Risk: a subgroup analysis of the OPT-BIRISK randomized clinical trial” [Eur. J. Pharmacol. 1006 5 (2025) 178151]

勘误:“基于GRACE评分的高缺血和出血风险急性冠状动脉综合征患者氯吡格雷单药治疗与延长DAPT的对比:OPT-BIRISK随机临床试验的亚组分析”[Eur. J. Pharmacol. 1006 5 (2025) 178151]

2025-10-100
OAAI
S-nitrosoglutathione reductase as a therapeutic target for diabetic vascular complications in rodent models

S-亚硝基谷胱甘肽还原酶作为啮齿动物模型中糖尿病血管并发症的治疗靶点

2025-10-010
PRE
Comparison of clopidogrel monotherapy versus prolonged DAPT based on the GRACE risk score in patients with acute coronary syndromes at high ischemic and bleeding risk: a subgroup analysis of the OPT-BIRISK randomized clinical trial

基于GRACE风险评分对急性冠状动脉综合征高缺血和高出血风险患者中氯吡格雷单药治疗与延长DAPT的对比:OPT-BIRISK随机临床试验的亚组分析

2025-09-130
PREAI
Efficacy and Safety of Clopidogrel and Ticagrelor in Acute Coronary Syndrome Patients with CYP2C19 Loss-of-Function Alleles After Percutaneous Coronary Intervention: Based on the GRACE Score

氯吡格雷和替格瑞洛在携带CYP2C19功能缺失等位基因的急性冠状动脉综合征患者经皮冠状动脉介入治疗后的疗效与安全性:基于GRACE评分

2025-08-070
OAAI
Long-term outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention without standard modifiable cardiovascular risk factors: findings from the OPT-CAD cohort

在没有标准可改变心血管危险因素的情况下接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者的长期预后: opt-cad队列的结果

2025-02-240
OAAI